Dr. Saniya Fayzullina
Staff Project Manager, Product Development at GRAIL, Inc.
Dr. Saniya has a BS in Neuroscience and Biology and a PhD in Pathobiology. She spent over a decade working with mice and rats to study disease and develop treatments for illnesses. (Lou Gehrig’s disease, spinal muscular atrophy, kidney disease, stroke, multiple sclerosis, and pain). She also worked as a technical writer at several companies, including 23andMe, where she wrote documents that contributed to 23andMe’s first FDA-approved test. Dr. Saniya currently works at GRAIL as a program manager, helping develop a test that detects multiple cancers.
Dr. Saniya presented at the Jobs of Tomorrow program on January 31st, 2020.